ANIXA BIOSCIENCES, INC. Deferred State and Local Income Tax Expense (Benefit)
ANIXA BIOSCIENCES, INC. (ANIX) reported Deferred State and Local Income Tax Expense (Benefit) of -$574.00 thousand for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-01-12
- ANIXA BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was -$574.00K.
- ANIXA BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was -$754.00K.
- ANIXA BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was -$583.00M.
- ANIXA BIOSCIENCES, INC. deferred state and local income tax expense (benefit) for fiscal 2022 was -$350.00M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-10-31 | -$574.00K 10-K · filed 2026-01-12 | |
| 2024-10-31 | -$754.00K 10-K · filed 2026-01-12 | -$754.00M 10-K · filed 2025-01-10 |
| 2023-10-31 | -$583.00M 10-K · filed 2025-01-10 | |
| 2022-10-31 | -$350.00M 10-K · filed 2024-01-16 | -$350.00K 10-K · filed 2023-01-04 |
| 2021-10-31 | -$129.00K 10-K · filed 2023-01-04 | |
| 2020-10-31 | -$800.00K 10-K · filed 2022-01-04 | |
| 2019-10-31 | -$995.00K 10-K · filed 2021-01-07 | |
| 2018-10-31 | -$1.21M 10-K · filed 2020-01-09 | |
| 2017-10-31 | $4.35M 10-K · filed 2019-01-11 | -$4.35M 10-K · filed 2018-01-09 |
| 2016-10-31 | -$134.00K 10-K · filed 2018-01-09 | |
| 2015-10-31 | -$120.00K 10-K · filed 2016-12-08 | |
| 2014-10-31 | -$1.00K 10-K · filed 2015-12-23 | |
| 2013-10-31 | $3.00K 10-K · filed 2015-01-29 | |
| 2012-10-31 | $32.00K 10-K/A · filed 2014-01-17 | |
| 2011-10-31 | -$10.00K 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |